share_log

2U Analyst Ratings

Benzinga ·  Nov 13, 2023 16:49
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/13/2023 80.85% Piper Sandler $4 → $1.7 Maintains Neutral
11/13/2023 Citigroup Downgrades Buy → Neutral
11/10/2023 Barrington Research Downgrades Outperform → Market Perform
11/10/2023 112.77% Morgan Stanley $3 → $2 Maintains Equal-Weight
11/10/2023 219.15% Needham $9 → $3 Maintains Buy
11/10/2023 59.57% Cantor Fitzgerald $5.3 → $1.5 Downgrades Overweight → Neutral
10/23/2023 219.15% Morgan Stanley $4.5 → $3 Maintains Equal-Weight
08/10/2023 814.89% Goldman Sachs $10 → $8.6 Maintains Buy
08/10/2023 644.68% Barrington Research → $7 Reiterates Outperform → Outperform
08/10/2023 325.53% Piper Sandler $6 → $4 Maintains Neutral
08/09/2023 463.83% Cantor Fitzgerald $7.4 → $5.3 Maintains Overweight
08/09/2023 538.3% Credit Suisse $7.5 → $6 Maintains Neutral
08/09/2023 378.72% Morgan Stanley $6.5 → $4.5 Maintains Equal-Weight
08/09/2023 857.45% Needham $15 → $9 Maintains Buy
08/09/2023 325.53% Baird $12 → $4 Downgrades Outperform → Neutral
05/31/2023 538.3% BMO Capital $9 → $6 Maintains Outperform
05/17/2023 1495.74% Needham → $15 Reiterates Buy → Buy
04/28/2023 857.45% BMO Capital $11 → $9 Maintains Outperform
04/28/2023 963.83% Goldman Sachs $11.5 → $10 Maintains Buy
04/27/2023 963.83% Barrington Research → $10 Reiterates → Outperform
04/27/2023 697.87% Credit Suisse $9 → $7.5 Maintains Neutral
04/27/2023 687.23% Cantor Fitzgerald → $7.4 Upgrades Neutral → Overweight
04/27/2023 1495.74% Needham → $15 Reiterates → Buy
04/27/2023 538.3% Piper Sandler $10 → $6 Maintains Neutral
04/21/2023 591.49% Morgan Stanley $10 → $6.5 Maintains Equal-Weight
04/06/2023 963.83% Piper Sandler → $10 Reiterates → Neutral
03/31/2023 963.83% Morgan Stanley $11 → $10 Maintains Equal-Weight
03/22/2023 910.64% Cantor Fitzgerald → $9.5 Maintains Neutral
03/22/2023 857.45% Credit Suisse $11 → $9 Maintains Neutral
03/22/2023 1495.74% Needham → $15 Reiterates → Buy
02/06/2023 1070.21% BMO Capital $9 → $11 Maintains Outperform
02/06/2023 1495.74% Barrington Research $9 → $15 Reiterates → Outperform
02/03/2023 910.64% Cantor Fitzgerald $8 → $9.5 Reiterates → Neutral
02/03/2023 1070.21% Morgan Stanley $10 → $11 Maintains Equal-Weight
02/03/2023 1495.74% Needham → $15 Reiterates → Buy
02/03/2023 963.83% Piper Sandler $7 → $10 Maintains Neutral
01/10/2023 1229.79% Goldman Sachs $14.4 → $12.5 Maintains Buy
11/22/2022 751.06% Credit Suisse → $8 Initiates Coverage On → Neutral
11/09/2022 857.45% BMO Capital $8 → $9 Maintains Outperform
11/09/2022 963.83% Morgan Stanley $12 → $10 Maintains Equal-Weight
11/08/2022 1431.91% Goldman Sachs $16.5 → $14.4 Maintains Buy
11/08/2022 644.68% Piper Sandler $8 → $7 Upgrades Underweight → Neutral
08/01/2022 1176.6% Morgan Stanley $16 → $12 Maintains Equal-Weight
07/29/2022 1495.74% Needham $19 → $15 Maintains Buy
07/29/2022 751.06% Piper Sandler $9 → $8 Maintains Underweight
07/25/2022 1070.21% Macquarie → $11 Downgrades Outperform → Neutral
05/25/2022 857.45% Piper Sandler $10 → $9 Downgrades Neutral → Underweight
05/06/2022 1602.13% Morgan Stanley $17 → $16 Maintains Equal-Weight
05/06/2022 963.83% Piper Sandler $15 → $10 Maintains Neutral
05/06/2022 1921.28% Needham $28 → $19 Maintains Buy
04/14/2022 1708.51% Morgan Stanley $22 → $17 Maintains Equal-Weight
03/30/2022 1176.6% Cantor Fitzgerald → $12 Initiates Coverage On → Neutral
02/10/2022 William Blair Downgrades Outperform → Market Perform
02/10/2022 1708.51% Berenberg → $17 Downgrades Buy → Hold
02/10/2022 2878.72% Needham $50 → $28 Maintains Buy
02/02/2022 2559.57% Goldman Sachs $42 → $25 Upgrades Neutral → Buy
01/27/2022 2453.19% Morgan Stanley $28 → $24 Maintains Equal-Weight
01/13/2022 2346.81% Piper Sandler $37 → $23 Downgrades Overweight → Neutral
12/09/2021 2878.72% Morgan Stanley $37 → $28 Maintains Equal-Weight
11/10/2021 5219.15% Needham $61 → $50 Maintains Buy
11/10/2021 3836.17% Piper Sandler $54 → $37 Maintains Overweight
07/30/2021 5751.06% Morgan Stanley $53 → $55 Maintains Equal-Weight
07/12/2021 Macquarie Upgrades Neutral → Outperform
04/29/2021 5538.3% Morgan Stanley $55 → $53 Maintains Equal-Weight
02/12/2021 5751.06% Morgan Stanley $42 → $55 Maintains Equal-Weight
02/12/2021 6389.36% Needham $50 → $61 Maintains Buy
02/12/2021 6282.98% Piper Sandler $49 → $60 Maintains Overweight
01/26/2021 4368.09% Morgan Stanley $39 → $42 Maintains Equal-Weight
11/24/2020 4048.94% Morgan Stanley → $39 Initiates Coverage On → Equal-Weight
10/28/2020 4900% Piper Sandler $46 → $47 Maintains Overweight
07/31/2020 5006.38% Credit Suisse $28 → $48 Upgrades Neutral → Outperform
07/31/2020 5219.15% Needham $44 → $50 Maintains Buy
07/16/2020 5219.15% Jefferies → $50 Initiates Coverage On → Buy
06/30/2020 5219.15% Citigroup $28 → $50 Maintains Buy
06/30/2020 Keybanc Initiates Coverage On → Sector Weight
05/22/2020 4368.09% Piper Sandler → $42 Initiates Coverage On → Overweight
05/21/2020 4580.85% Needham $30 → $44 Maintains Buy
05/18/2020 4474.47% BMO Capital $31 → $43 Maintains Outperform
05/04/2020 3091.49% Baird → $30 Upgrades Neutral → Outperform
05/01/2020 2878.72% Credit Suisse $32 → $28 Maintains Neutral
05/01/2020 3091.49% Needham $25 → $30 Maintains Buy
03/25/2020 2559.57% Needham → $25 Upgrades Hold → Buy
03/16/2020 3410.64% BMO Capital $26 → $33 Upgrades Market Perform → Outperform
03/11/2020 3091.49% Baird $28 → $30 Maintains Neutral
02/07/2020 Keybanc Downgrades Overweight → Sector Weight
02/07/2020 William Blair Upgrades Market Perform → Outperform
11/13/2019 2665.96% DA Davidson $17 → $26 Maintains Neutral
11/13/2019 2453.19% BMO Capital $20 → $24 Maintains Market Perform
11/13/2019 3304.26% Credit Suisse $42 → $32 Maintains Neutral
10/17/2019 1708.51% DA Davidson $27 → $17 Maintains Neutral
09/25/2019 2346.81% Keybanc $37 → $23 Maintains Overweight
08/08/2019 2027.66% Citigroup → $20 Reinstates → Buy
08/08/2019 2027.66% Citigroup → $20 Reinstates → Buy
08/01/2019 1708.51% Berenberg $81 → $17 Downgrades Buy → Hold
07/31/2019 Needham Downgrades Buy → Hold
07/31/2019 Oppenheimer Downgrades Outperform → Perform
07/31/2019 Macquarie Downgrades Outperform → Neutral
07/31/2019 2985.11% Baird $58 → $29 Downgrades Outperform → Neutral
07/17/2019 5857.45% Keybanc → $56 Initiates Coverage On → Overweight
05/08/2019 6282.98% BMO Capital $83 → $60 Maintains Outperform
05/08/2019 5751.06% Credit Suisse $85 → $55 Downgrades Outperform → Neutral
03/06/2019 10751.06% Berenberg → $102 Initiates Coverage On → Buy
02/26/2019 8942.55% Credit Suisse $80 → $85 Maintains Outperform
02/26/2019 8729.79% BMO Capital $72 → $83 Maintains Outperform
02/26/2019 8410.64% Keybanc $65 → $80 Maintains Overweight
01/08/2019 6814.89% Keybanc $80 → $65 Maintains Overweight

What is the target price for 2U (TWOU)?

The latest price target for 2U (NASDAQ: TWOU) was reported by Piper Sandler on November 13, 2023. The analyst firm set a price target for $1.70 expecting TWOU to rise to within 12 months (a possible 80.85% upside). 38 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for 2U (TWOU)?

The latest analyst rating for 2U (NASDAQ: TWOU) was provided by Piper Sandler, and 2U maintained their neutral rating.

When is the next analyst rating going to be posted or updated for 2U (TWOU)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 2U, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 2U was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.

Is the Analyst Rating 2U (TWOU) correct?

While ratings are subjective and will change, the latest 2U (TWOU) rating was a maintained with a price target of $4.00 to $1.70. The current price 2U (TWOU) is trading at is $0.94, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment